Vanessa Williams

532 total citations
19 papers, 397 citations indexed

About

Vanessa Williams is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Vanessa Williams has authored 19 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Endocrinology, Diabetes and Metabolism, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Surgery. Recurrent topics in Vanessa Williams's work include Renin-Angiotensin System Studies (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Apelin-related biomedical research (2 papers). Vanessa Williams is often cited by papers focused on Renin-Angiotensin System Studies (5 papers), Chronic Kidney Disease and Diabetes (3 papers) and Apelin-related biomedical research (2 papers). Vanessa Williams collaborates with scholars based in United States, Canada and South Korea. Vanessa Williams's co-authors include James W. Scholey, Michael Brudno, Marc Fiume, Rohan John, Ana Konvalinka, Xiao‐Hua Zhou, Fei Fang, Gavin Y. Oudit, Xuewen Song and York Pei and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Vanessa Williams

15 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vanessa Williams United States 10 147 97 61 60 51 19 397
Marina Sapojnikov Israel 8 80 0.5× 85 0.9× 69 1.1× 79 1.3× 84 1.6× 12 340
Carine Prisco Arnoni Brazil 10 82 0.6× 45 0.5× 41 0.7× 41 0.7× 17 0.3× 42 354
Tracy Clarke United States 6 119 0.8× 94 1.0× 50 0.8× 145 2.4× 17 0.3× 7 426
Kojiro Yamamoto Japan 12 137 0.9× 52 0.5× 36 0.6× 133 2.2× 35 0.7× 37 422
J. J. Weening Netherlands 6 92 0.6× 71 0.7× 26 0.4× 119 2.0× 32 0.6× 12 403
Tatyana Peresleni United States 8 148 1.0× 75 0.8× 18 0.3× 149 2.5× 79 1.5× 12 598
Yiqiong Ma China 14 276 1.9× 42 0.4× 31 0.5× 199 3.3× 49 1.0× 19 596
Gourav Bhardwaj United States 15 311 2.1× 70 0.7× 26 0.4× 32 0.5× 28 0.5× 24 537
Beilei Zhao China 11 197 1.3× 29 0.3× 20 0.3× 106 1.8× 29 0.6× 20 430
Zongwei Lin China 10 204 1.4× 69 0.7× 28 0.5× 20 0.3× 17 0.3× 19 388

Countries citing papers authored by Vanessa Williams

Since Specialization
Citations

This map shows the geographic impact of Vanessa Williams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vanessa Williams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vanessa Williams more than expected).

Fields of papers citing papers by Vanessa Williams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vanessa Williams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vanessa Williams. The network helps show where Vanessa Williams may publish in the future.

Co-authorship network of co-authors of Vanessa Williams

This figure shows the co-authorship network connecting the top 25 collaborators of Vanessa Williams. A scholar is included among the top collaborators of Vanessa Williams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vanessa Williams. Vanessa Williams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Williams, Vanessa, et al.. (2024). Cardiometabolic comorbidities and complications of obesity and chronic kidney disease (CKD). Journal of Clinical & Translational Endocrinology. 36. 100341–100341. 12 indexed citations
2.
Williams, Vanessa, et al.. (2023). Abstract #1401109: Quetiapine-induced Hypoglycemia in an Elderly Non-diabetic Patient with Dementia. Endocrine Practice. 29(5). S9–S10.
3.
Williams, Vanessa, et al.. (2023). Impact of Perioperative Dexamethasone on Hospital Length of Stay and Glycemic Control in Patients With Type 2 Diabetes Undergoing Total Hip Arthroplasty. SHILAP Revista de lepidopterología. 10(1). 4–12. 5 indexed citations
4.
Williams, Vanessa, et al.. (2023). Abstract #1406235: Silent Corticotroph Adenomas are More Aggressive than Other Nonfunctional Pituitary Adenomas. Endocrine Practice. 29(5). S78–S78.
5.
Williams, Vanessa, et al.. (2022). Abstract #1176076: Secondary Hypoparathyroidism and Intracranial Calcifications. Endocrine Practice. 28(5). S81–S82.
6.
Scholey, James W., et al.. (2021). Sex and kidney ACE2 expression in primary focal segmental glomerulosclerosis: A NEPTUNE study. PLoS ONE. 16(6). e0252758–e0252758. 6 indexed citations
7.
Williams, Vanessa, et al.. (2021). Pheochromocytoma as the Etiology of Cushing Syndrome Through Paracrine ACTH Signaling. Journal of the Endocrine Society. 5(Supplement_1). A148–A148.
8.
Williams, Vanessa, Ana Konvalinka, Xuewen Song, et al.. (2020). Connectivity mapping of a chronic kidney disease progression signature identified lysine deacetylases as novel therapeutic targets. Kidney International. 98(1). 116–132. 22 indexed citations
9.
Williams, Vanessa, et al.. (2020). Kidney ACE2 expression: Implications for chronic kidney disease. PLoS ONE. 15(10). e0241534–e0241534. 27 indexed citations
10.
Petry, Natasha, Eric Larson, Vanessa Williams, et al.. (2019). CYP2C19 Genotype, Physician Prescribing Pattern, and Risk for Long QT on Serotonin Selective Reuptake Inhibitors. Pharmacogenomics. 20(5). 343–351. 6 indexed citations
11.
Shen, Xinglei, et al.. (2018). MRI findings of absorbable hydrogel spacer for prostate cancer therapy: a pictorial review. Abdominal Radiology. 44(1). 247–251. 6 indexed citations
12.
Bae, Eun Hui, Fei Fang, Vanessa Williams, et al.. (2017). Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome. Kidney International. 91(6). 1347–1361. 36 indexed citations
13.
Williams, Vanessa & James W. Scholey. (2017). Angiotensin-converting enzyme 2 and renal disease. Current Opinion in Nephrology & Hypertension. 27(1). 35–41. 45 indexed citations
14.
Bae, Eun Hui, Ana Konvalinka, Fei Fang, et al.. (2015). Characterization of the Intrarenal Renin-Angiotensin System in Experimental Alport Syndrome. American Journal Of Pathology. 185(5). 1423–1435. 27 indexed citations
15.
Fang, Fei, Amanda Hu, George C. Liu, et al.. (2015). Deletion of the gene for adiponectin accelerates diabetic nephropathy in the Ins2 +/C96Y mouse. Diabetologia. 58(7). 1668–1678. 28 indexed citations
16.
Fang, Fei, Xiao‐Hua Zhou, Heather N. Reich, et al.. (2013). Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion Injury. PLoS ONE. 8(8). e71433–e71433. 58 indexed citations
17.
Fiume, Marc, et al.. (2010). Savant: genome browser for high-throughput sequencing data. Bioinformatics. 26(16). 1938–1944. 91 indexed citations
18.
Rice, Valerie Montgomery, et al.. (1996). Tumour necrosis factor-alpha inhibits follicle stimulating hormone-induced granulosa cell oestradiol secretion in the human: dependence on size of follicle. Human Reproduction. 11(6). 1256–1261. 23 indexed citations
19.
Metz, Henry S, et al.. (1969). Use of a Computer in a Glaucoma Clinic. Archives of Ophthalmology. 81(2). 155–158. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026